Lung cancer and its association with chronic obstructive pulmonary disease: Update on nexus of epigenetics

Isaac K. Sundar, Nandita Mullapudi, Hongwei Yao, Simon D. Spivack, Irfan Rahman

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Chronic obstructive pulmonary disease (COPD) and lung cancer are the leading causes of morbidity and mortality worldwide. The current research is focused on identifying the common and disparate events involved in epigenetic modifications that concurrently occur during the pathogenesis of COPD and lung cancer. The purpose of this review is to describe the current knowledge and understanding of epigenetic modifications in pathogenesis of COPD and lung cancer. RECENT FINDINGS: This review provides an update on advances of how epigenetic modifications are linked to COPD and lung cancer, and their commonalities and disparities. The key epigenetic modification enzymes (e.g. DNA methyltransferases - CpG methylation, histone acetylases/deacetylases and histone methyltransferases/demethylases) that are identified to play an important role in COPD and lung tumorigenesis and progression are described in this review. SUMMARY: Distinct DNA methyltransferases and histone modification enzymes are differentially involved in pathogenesis of lung cancer and COPD, although some of the modifications are common. Understanding the epigenetic modifications involved in pathogenesis of lung cancer or COPD with respect to common and disparate mechanisms will lead to targeting of epigenetic therapies against these disorders.

Original languageEnglish (US)
Pages (from-to)279-285
Number of pages7
JournalCurrent Opinion in Pulmonary Medicine
Volume17
Issue number4
DOIs
StatePublished - Jul 2011

Fingerprint

Epigenomics
Chronic Obstructive Pulmonary Disease
Lung Neoplasms
Methyltransferases
Histone Code
Histone Demethylases
Nexus
Histone Acetyltransferases
Histone Deacetylases
DNA
Enzymes
Methylation
Carcinogenesis
Morbidity
Lung
Mortality
Research

Keywords

  • chromatin
  • chronic obstructive pulmonary disease
  • epigenetics
  • histones
  • lung cancer
  • methylation

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Lung cancer and its association with chronic obstructive pulmonary disease : Update on nexus of epigenetics. / Sundar, Isaac K.; Mullapudi, Nandita; Yao, Hongwei; Spivack, Simon D.; Rahman, Irfan.

In: Current Opinion in Pulmonary Medicine, Vol. 17, No. 4, 07.2011, p. 279-285.

Research output: Contribution to journalArticle

Sundar, Isaac K. ; Mullapudi, Nandita ; Yao, Hongwei ; Spivack, Simon D. ; Rahman, Irfan. / Lung cancer and its association with chronic obstructive pulmonary disease : Update on nexus of epigenetics. In: Current Opinion in Pulmonary Medicine. 2011 ; Vol. 17, No. 4. pp. 279-285.
@article{7c77a241c6bb46bbb7a4d891569ff93d,
title = "Lung cancer and its association with chronic obstructive pulmonary disease: Update on nexus of epigenetics",
abstract = "PURPOSE OF REVIEW: Chronic obstructive pulmonary disease (COPD) and lung cancer are the leading causes of morbidity and mortality worldwide. The current research is focused on identifying the common and disparate events involved in epigenetic modifications that concurrently occur during the pathogenesis of COPD and lung cancer. The purpose of this review is to describe the current knowledge and understanding of epigenetic modifications in pathogenesis of COPD and lung cancer. RECENT FINDINGS: This review provides an update on advances of how epigenetic modifications are linked to COPD and lung cancer, and their commonalities and disparities. The key epigenetic modification enzymes (e.g. DNA methyltransferases - CpG methylation, histone acetylases/deacetylases and histone methyltransferases/demethylases) that are identified to play an important role in COPD and lung tumorigenesis and progression are described in this review. SUMMARY: Distinct DNA methyltransferases and histone modification enzymes are differentially involved in pathogenesis of lung cancer and COPD, although some of the modifications are common. Understanding the epigenetic modifications involved in pathogenesis of lung cancer or COPD with respect to common and disparate mechanisms will lead to targeting of epigenetic therapies against these disorders.",
keywords = "chromatin, chronic obstructive pulmonary disease, epigenetics, histones, lung cancer, methylation",
author = "Sundar, {Isaac K.} and Nandita Mullapudi and Hongwei Yao and Spivack, {Simon D.} and Irfan Rahman",
year = "2011",
month = "7",
doi = "10.1097/MCP.0b013e3283477533",
language = "English (US)",
volume = "17",
pages = "279--285",
journal = "Current Opinion in Pulmonary Medicine",
issn = "1070-5287",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Lung cancer and its association with chronic obstructive pulmonary disease

T2 - Update on nexus of epigenetics

AU - Sundar, Isaac K.

AU - Mullapudi, Nandita

AU - Yao, Hongwei

AU - Spivack, Simon D.

AU - Rahman, Irfan

PY - 2011/7

Y1 - 2011/7

N2 - PURPOSE OF REVIEW: Chronic obstructive pulmonary disease (COPD) and lung cancer are the leading causes of morbidity and mortality worldwide. The current research is focused on identifying the common and disparate events involved in epigenetic modifications that concurrently occur during the pathogenesis of COPD and lung cancer. The purpose of this review is to describe the current knowledge and understanding of epigenetic modifications in pathogenesis of COPD and lung cancer. RECENT FINDINGS: This review provides an update on advances of how epigenetic modifications are linked to COPD and lung cancer, and their commonalities and disparities. The key epigenetic modification enzymes (e.g. DNA methyltransferases - CpG methylation, histone acetylases/deacetylases and histone methyltransferases/demethylases) that are identified to play an important role in COPD and lung tumorigenesis and progression are described in this review. SUMMARY: Distinct DNA methyltransferases and histone modification enzymes are differentially involved in pathogenesis of lung cancer and COPD, although some of the modifications are common. Understanding the epigenetic modifications involved in pathogenesis of lung cancer or COPD with respect to common and disparate mechanisms will lead to targeting of epigenetic therapies against these disorders.

AB - PURPOSE OF REVIEW: Chronic obstructive pulmonary disease (COPD) and lung cancer are the leading causes of morbidity and mortality worldwide. The current research is focused on identifying the common and disparate events involved in epigenetic modifications that concurrently occur during the pathogenesis of COPD and lung cancer. The purpose of this review is to describe the current knowledge and understanding of epigenetic modifications in pathogenesis of COPD and lung cancer. RECENT FINDINGS: This review provides an update on advances of how epigenetic modifications are linked to COPD and lung cancer, and their commonalities and disparities. The key epigenetic modification enzymes (e.g. DNA methyltransferases - CpG methylation, histone acetylases/deacetylases and histone methyltransferases/demethylases) that are identified to play an important role in COPD and lung tumorigenesis and progression are described in this review. SUMMARY: Distinct DNA methyltransferases and histone modification enzymes are differentially involved in pathogenesis of lung cancer and COPD, although some of the modifications are common. Understanding the epigenetic modifications involved in pathogenesis of lung cancer or COPD with respect to common and disparate mechanisms will lead to targeting of epigenetic therapies against these disorders.

KW - chromatin

KW - chronic obstructive pulmonary disease

KW - epigenetics

KW - histones

KW - lung cancer

KW - methylation

UR - http://www.scopus.com/inward/record.url?scp=79958820786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958820786&partnerID=8YFLogxK

U2 - 10.1097/MCP.0b013e3283477533

DO - 10.1097/MCP.0b013e3283477533

M3 - Article

C2 - 21537190

AN - SCOPUS:79958820786

VL - 17

SP - 279

EP - 285

JO - Current Opinion in Pulmonary Medicine

JF - Current Opinion in Pulmonary Medicine

SN - 1070-5287

IS - 4

ER -